返回
NervGen Pharma Corp（NGENF）价格
NGENF 股价走势图
NGENF 收益
NervGen Pharma Corp
$5.63
2.92%
$0.16
收盘价：Jan 16, 16:00:00 GMT-5
$5.63
0%
$0
盘前：Jan 20, 07:41:33 GMT-5
关键数据
前收盘价
$5.47
开盘价
$5.3
当日区间
$5.3 - $5.81
52周范围
$1.5 - $6.3
交易量
27.4K
平均成交量
143.6K
每股收益（TTM）
-0.26
股息收益率
--
市值
$445.9M
什么是 NGENF？
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.